Streetbeat News

Regulatory

OGI

VFF

Germany is emerging as a leader in the European cannabis market, with significant growth potential due to recent decriminalization. Companies like Village Farms International and Organigram Holdings are focusing on this market, leveraging EU GMP certification for international expansion. Canada faces profitability challenges due to high taxes, while Australia shows promise in non-combustible cannabis products.

Portfolio Pulse from Nicolás Jose Rodriguez

October 14, 2024 | 3:26 pm

BFRI

Biofrontera Inc. has announced the database lock for its Phase 3 study of Ameluz-Photodynamic Therapy in treating superficial basal cell carcinoma. The study's data is now ready for analysis, with interim results expected in November 2024. The final submission to the FDA is targeted for Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:31 pm

EIS

FXI

ISRA

China's Foreign Minister expressed willingness to resume exchanges with Israel as the situation eases, according to state media.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:26 pm

EIS

FXI

ISRA

China's Foreign Minister has urged for an immediate, complete, and permanent ceasefire in Gaza and the release of all hostages during phone talks with the Israeli Foreign Minister.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:12 pm

SPY

Federal Reserve's Neel Kashkari suggests that the neutral interest rate is likely higher now compared to pre-pandemic levels. This could impact market expectations and interest rate-sensitive assets.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 2:08 pm

FXI

China is considering issuing 6 trillion yuan in ultra-long special treasury bonds over three years to stimulate its slowing economy. The funds will help local governments manage off-the-books debts.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:46 pm

LLY

The FDA is reconsidering its ban on compounding pharmacies supplying cheaper versions of Eli Lilly's weight loss and diabetes drugs. This follows a complaint from compounding groups and a shortage of Eli Lilly's tirzepatide injection, branded as Mounjaro and Zepbound.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 1:43 pm

FXI

VGK

The EU has received price undertaking offers from the Chinese Chamber of Commerce and separate EV exporters regarding electric vehicles. However, reaching an agreement by the end of October seems challenging. A single minimum price as an alternative to tariffs is not feasible.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:28 pm

JSPR

Jasper Therapeutics Inc (NASDAQ:JSPR) stock is trading higher after reporting positive preliminary data from its SPOTLIGHT Phase 1b/2a study of briquilimab for cold urticaria and symptomatic dermographism. The study showed high clinical response rates and no serious adverse events, leading to regulatory clearance for further trials.

Portfolio Pulse from Vandana Singh

October 14, 2024 | 1:22 pm

NTBL

Trading for NTBL was halted at 9:17:54 a.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released, which could impact its stock price.

Portfolio Pulse from Benzinga Newsdesk

October 14, 2024 | 1:18 pm